107
Views
3
CrossRef citations to date
0
Altmetric
Original Research

NDC1 is a Prognostic Biomarker and Associated with Immune Infiltrates in Colon Cancer

, ORCID Icon, , & ORCID Icon
Pages 8811-8817 | Published online: 25 Nov 2021

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Stoffel EM, Murphy CC. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology. 2020;158(2):341–353. doi:10.1053/j.gastro.2019.07.055
  • White A, Joseph D, Rim SH, Johnson CJ, Coleman MP, Allemani C. Colon cancer survival in the United States by race and stage (2001–2009): findings from the CONCORD-2 study. Cancer. 2017;123(Suppl24):5014–5036. doi:10.1002/cncr.31076
  • Chernyavskiy P, Kennerley VM, Jemal A, Little MP, Rosenberg PS. Heterogeneity of colon and rectum cancer incidence across 612 SEER counties, 2000–2014. Int J Cancer. 2019;144(8):1786–1795. doi:10.1002/ijc.31776
  • Bradley CJ, Yabroff KR, Warren JL, Zeruto C, Chawla N, Lamont EB. Trends in the treatment of metastatic colon and rectal cancer in elderly patients. Med Care. 2016;54(5):490–497. doi:10.1097/MLR.0000000000000510
  • Yu C, Zhang Y. Development and validation of a prognostic nomogram for early-onset colon cancer. Biosci Rep. 2019;39(6). doi:10.1042/BSR20181781
  • Ulanja MB, Rishi M, Beutler BD, et al. Colon cancer sidedness, presentation, and survival at different stages. J Oncol. 2019;2019:4315032. doi:10.1155/2019/4315032
  • Yamazumi Y, Kamiya A, Nishida A, et al. The transmembrane nucleoporin NDC1 is required for targeting of ALADIN to nuclear pore complexes. Biochem Biophys Res Commun. 2009;389(1):100–104. doi:10.1016/j.bbrc.2009.08.096
  • Lai TH, Wu YY, Wang YY, et al. SEPT12-NDC1 complexes are required for mammalian spermiogenesis. Int J Mol Sci. 2016;17(11):1911. doi:10.3390/ijms17111911
  • Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678. doi:10.1038/s41587-020-0546-8
  • Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
  • Li B, Severson E, Pignon JC, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17(1):174. doi:10.1186/s13059-016-1028-7
  • Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics (Oxford, England). 2007;23(23):3251–3253. doi:10.1093/bioinformatics/btm369
  • Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
  • Kassambara A, Kosinski M, Biecek P. Survminer: drawing survival curves using ‘ggplot2ʹ; 2019. Available from: https://CRAN.R-project.org/package=survminer. Accessed November 15, 2021.
  • Azimi F, Scolyer RA, Rumcheva P, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30(21):2678–2683. doi:10.1200/JCO.2011.37.8539
  • Wong PF, Wei W, Smithy JW, et al. Multiplex quantitative analysis of tumor-infiltrating lymphocytes and immunotherapy outcome in metastatic melanoma. Clin Cancer Res. 2019;25(8):2442–2449. doi:10.1158/1078-0432.CCR-18-2652
  • Stavru F, Hülsmann BB, Spang A, Hartmann E, Cordes VC, Görlich D. NDC1: a crucial membrane-integral nucleoporin of metazoan nuclear pore complexes. J Cell Biol. 2006;173(4):509–519. doi:10.1083/jcb.200601001
  • Chen J, Smoyer CJ, Slaughter BD, Unruh JR, Jaspersen SL. The SUN protein Mps3 controls Ndc1 distribution and function on the nuclear membrane. J Cell Biol. 2014;204(4):523–539. doi:10.1083/jcb.201307043
  • Qiao W, Han Y, Jin W, et al. Overexpression and biological function of TMEM48 in non-small cell lung carcinoma. Tumor Biol. 2016;37(2):2575–2586. doi:10.1007/s13277-015-4014-x
  • Akkafa F, Koyuncu İ, Temiz E, Dagli H, Dïlmec F, Akbas H. miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line. Biochem Biophys Res Commun. 2018;503(1):323–329. doi:10.1016/j.bbrc.2018.06.023